Cite
HARVARD Citation
Naing, A. et al. (2019). Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial. Lancet oncology. 20 (11), pp. 1544-1555. [Online].